论文部分内容阅读
头颈部恶性肿瘤约占全身恶性肿瘤的19.9%~30.2%,病理类型主要以鳞状细胞癌为主,手术和放疗是其主要治疗手段。尽管现在综合治疗被广泛应用,但局部区域肿瘤未控、复发和转移仍然是治疗失败的主要原因。放射性粒子组织间植入近距离放疗是对外科手术及放疗缺陷进行互补的一种新型治疗方法,2007-01-2008-06期间我们对38例头颈部鳞状细胞癌术后复发和淋巴结转移患者施行125I放射性粒子组织间植入近距离放疗,疗效较好,现报告如下。
Head and neck cancer accounted for about 19.9% to 30.2% of malignant tumors, the main pathological type of squamous cell carcinoma, surgery and radiotherapy is the main treatment. Although comprehensive treatment is now widely used, but uncontrolled local tumor recurrence and metastasis is still the main reason for treatment failure. Radiosensory interstitial brachytherapy is a new treatment method that complements surgical and radiotherapy defects. During the period of 2007-01-2008-06, we retrospectively analyzed the recurrence and lymph node metastasis of 38 cases of head and neck squamous cell carcinoma Patients with 125I radioactive seeds interstitial brachytherapy, the curative effect is better, are as follows.